1	Suppression	_	NN	_	_	0	ROOT	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	re-expression	_	NN	_	_	2	CONJ	_	_
4	of	_	IN	_	_	1	NMOD	_	_
5	transformed	_	VBN	_	_	6	NMOD	_	_
6	phenotype	_	NN	_	_	4	PMOD	_	_
7	in	_	IN	_	_	1	NMOD	_	_
8	hybrids	_	NNS	_	_	7	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	HA-ras-1-transformed	_	JJ	_	_	12	NMOD	_	_
11	rat-1	_	NN	_	_	12	NMOD	_	_
12	cells	_	NNS	_	_	9	PMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	early-passage	_	JJ	_	_	17	NMOD	_	_
15	rat	_	NN	_	_	17	NMOD	_	_
16	embryonic	_	JJ	_	_	17	NMOD	_	_
17	fibroblasts	_	NNS	_	_	13	CONJ	_	_
18	.	_	.	_	_	1	P	_	_
		
1	Rat-1	_	NN	_	_	2	NMOD	_	_
2	cells	_	NNS	_	_	18	VMOD	_	_
3	which	_	WDT	_	_	4	VMOD	_	_
4	had	_	VBD	_	_	2	NMOD	_	_
5	been	_	VBN	_	_	4	VC	_	_
6	transformed	_	VBN	_	_	5	VC	_	_
7	with	_	IN	_	_	6	VMOD	_	_
8	the	_	DT	_	_	11	NMOD	_	_
9	activated	_	VBN	_	_	11	NMOD	_	_
10	Ha-ras-1	_	NN	_	_	11	NMOD	_	_
11	gene	_	NN	_	_	7	PMOD	_	_
12	from	_	IN	_	_	11	NMOD	_	_
13	human	_	JJ	_	_	17	NMOD	_	_
14	EJ	_	NN	_	_	17	NMOD	_	_
15	bladder	_	NN	_	_	17	NMOD	_	_
16	carcinoma	_	NN	_	_	17	NMOD	_	_
17	cells	_	NNS	_	_	12	PMOD	_	_
18	were	_	VBD	_	_	0	ROOT	_	_
19	fused	_	VBN	_	_	18	VC	_	_
20	with	_	IN	_	_	19	VMOD	_	_
21	diploid	_	JJ	_	_	24	NMOD	_	_
22	embryonic	_	JJ	_	_	24	NMOD	_	_
23	rat	_	NN	_	_	24	NMOD	_	_
24	fibroblasts	_	NNS	_	_	20	PMOD	_	_
25	.	_	.	_	_	18	P	_	_
		
1	Four	_	CD	_	_	4	NMOD	_	_
2	selected	_	VBN	_	_	4	NMOD	_	_
3	cell	_	NN	_	_	4	NMOD	_	_
4	hybrids	_	NNS	_	_	5	VMOD	_	_
5	expressed	_	VBD	_	_	0	ROOT	_	_
6	the	_	DT	_	_	9	NMOD	_	_
7	human	_	JJ	_	_	9	NMOD	_	_
8	transforming	_	NN	_	_	9	NMOD	_	_
9	gene	_	NN	_	_	11	NMOD	_	_
10	product	_	NN	_	_	11	NMOD	_	_
11	p21	_	NN	_	_	5	VMOD	_	_
12	at	_	IN	_	_	5	VMOD	_	_
13	levels	_	NNS	_	_	12	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	10	_	CD	_	_	17	DEP	_	_
16	to	_	TO	_	_	17	DEP	_	_
17	30	_	CD	_	_	18	NMOD	_	_
18	%	_	NN	_	_	14	PMOD	_	_
19	compared	_	VBN	_	_	18	APPO	_	_
20	to	_	TO	_	_	19	VMOD	_	_
21	100	_	CD	_	_	22	NMOD	_	_
22	%	_	NN	_	_	20	PMOD	_	_
23	in	_	IN	_	_	22	NMOD	_	_
24	the	_	DT	_	_	27	NMOD	_	_
25	transformed	_	VBN	_	_	27	NMOD	_	_
26	parental	_	JJ	_	_	27	NMOD	_	_
27	cells	_	NNS	_	_	23	PMOD	_	_
28	.	_	.	_	_	5	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	hybrid	_	NN	_	_	3	NMOD	_	_
3	cells	_	NNS	_	_	7	VMOD	_	_
4	,	_	,	_	_	7	P	_	_
5	however	_	RB	_	_	7	VMOD	_	_
6	,	_	,	_	_	7	P	_	_
7	exhibited	_	VBD	_	_	0	ROOT	_	_
8	normal	_	JJ	_	_	9	NMOD	_	_
9	morphology	_	NN	_	_	7	VMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	anchorage	_	NN	_	_	12	NMOD	_	_
12	requirement	_	NN	_	_	9	COORD	_	_
13	for	_	IN	_	_	12	NMOD	_	_
14	proliferation	_	NN	_	_	13	PMOD	_	_
15	,	_	,	_	_	12	P	_	_
16	and	_	CC	_	_	12	COORD	_	_
17	largely	_	RB	_	_	18	AMOD	_	_
18	extended	_	VBN	_	_	20	NMOD	_	_
19	latency	_	NN	_	_	20	NMOD	_	_
20	periods	_	NNS	_	_	16	CONJ	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	tumorigenicity	_	NN	_	_	21	PMOD	_	_
23	in	_	IN	_	_	7	VMOD	_	_
24	newborn	_	JJ	_	_	25	NMOD	_	_
25	rats	_	NNS	_	_	23	PMOD	_	_
26	.	_	.	_	_	7	P	_	_
		
1	Tumorigenic	_	JJ	_	_	3	NMOD	_	_
2	hybrid	_	NN	_	_	3	NMOD	_	_
3	derivatives	_	NNS	_	_	4	VMOD	_	_
4	contained	_	VBD	_	_	0	ROOT	_	_
5	lower	_	JJR	_	_	6	NMOD	_	_
6	numbers	_	NNS	_	_	4	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	chromosomes	_	NNS	_	_	7	PMOD	_	_
9	than	_	IN	_	_	4	VMOD	_	_
10	the	_	DT	_	_	13	NMOD	_	_
11	tetraploid	_	JJ	_	_	13	NMOD	_	_
12	parental	_	JJ	_	_	13	NMOD	_	_
13	hybrids	_	NNS	_	_	9	PMOD	_	_
14	.	_	.	_	_	4	P	_	_
		
1	DNA	_	NN	_	_	7	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	6	NMOD	_	_
4	non-tumorigenic	_	JJ	_	_	6	NMOD	_	_
5	cell	_	NN	_	_	6	NMOD	_	_
6	hybrids	_	NNS	_	_	2	PMOD	_	_
7	transformed	_	VBD	_	_	0	ROOT	_	_
8	Rat-1	_	NN	_	_	9	NMOD	_	_
9	cells	_	NNS	_	_	7	VMOD	_	_
10	to	_	TO	_	_	7	VMOD	_	_
11	anchorage-independent	_	JJ	_	_	12	NMOD	_	_
12	proliferation	_	NN	_	_	10	PMOD	_	_
13	as	_	IN	_	_	7	VMOD	_	_
14	expected	_	VBN	_	_	13	SUB	_	_
15	for	_	IN	_	_	14	VMOD	_	_
16	the	_	DT	_	_	20	NMOD	_	_
17	transforming	_	NN	_	_	20	NMOD	_	_
18	human	_	JJ	_	_	20	NMOD	_	_
19	Ha-ras	_	NN	_	_	20	NMOD	_	_
20	gene	_	NN	_	_	15	PMOD	_	_
21	present	_	JJ	_	_	20	APPO	_	_
22	in	_	IN	_	_	21	AMOD	_	_
23	the	_	DT	_	_	25	NMOD	_	_
24	donor	_	NN	_	_	25	NMOD	_	_
25	DNA	_	NN	_	_	22	PMOD	_	_
26	.	_	.	_	_	7	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	conclude	_	VBP	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	transforming	_	NN	_	_	6	NMOD	_	_
6	properties	_	NNS	_	_	15	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	the	_	DT	_	_	11	NMOD	_	_
9	activated	_	VBN	_	_	11	NMOD	_	_
10	Ha-ras	_	NN	_	_	11	NMOD	_	_
11	gene	_	NN	_	_	7	PMOD	_	_
12	in	_	IN	_	_	11	NMOD	_	_
13	Rat-1	_	NN	_	_	14	NMOD	_	_
14	cells	_	NNS	_	_	12	PMOD	_	_
15	can	_	MD	_	_	3	SUB	_	_
16	be	_	VB	_	_	15	VC	_	_
17	suppressed	_	VBN	_	_	16	VC	_	_
18	at	_	IN	_	_	17	VMOD	_	_
19	the	_	DT	_	_	21	NMOD	_	_
20	post-translational	_	JJ	_	_	21	NMOD	_	_
21	level	_	NN	_	_	18	PMOD	_	_
22	by	_	IN	_	_	17	VMOD	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	presence	_	NN	_	_	22	PMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	the	_	DT	_	_	27	NMOD	_	_
27	genome	_	NN	_	_	25	PMOD	_	_
28	from	_	IN	_	_	24	NMOD	_	_
29	diploid	_	JJ	_	_	32	NMOD	_	_
30	embryonic	_	JJ	_	_	32	NMOD	_	_
31	rat	_	NN	_	_	32	NMOD	_	_
32	fibroblasts	_	NNS	_	_	28	PMOD	_	_
33	but	_	CC	_	_	15	COORD	_	_
34	additional	_	JJ	_	_	35	NMOD	_	_
35	controls	_	NNS	_	_	42	VMOD	_	_
36	of	_	IN	_	_	35	NMOD	_	_
37	expression	_	NN	_	_	36	PMOD	_	_
38	of	_	IN	_	_	37	NMOD	_	_
39	the	_	DT	_	_	41	NMOD	_	_
40	transforming	_	NN	_	_	41	NMOD	_	_
41	gene	_	NN	_	_	38	PMOD	_	_
42	are	_	VBP	_	_	33	CONJ	_	_
43	likely	_	JJ	_	_	42	VMOD	_	_
44	to	_	TO	_	_	43	AMOD	_	_
45	exist	_	VB	_	_	44	IM	_	_
46	.	_	.	_	_	2	P	_	_
		
1	Normal	_	JJ	_	_	2	NMOD	_	_
2	cells	_	NNS	_	_	3	VMOD	_	_
3	contain	_	VBP	_	_	0	ROOT	_	_
4	suppressor	_	NN	_	_	5	NMOD	_	_
5	gene(s)	_	NN	_	_	3	VMOD	_	_
6	which	_	WDT	_	_	7	VMOD	_	_
7	safeguard	_	VBP	_	_	5	NMOD	_	_
8	these	_	DT	_	_	9	NMOD	_	_
9	cells	_	NNS	_	_	7	VMOD	_	_
10	against	_	IN	_	_	7	VMOD	_	_
11	transformation	_	NN	_	_	10	PMOD	_	_
12	by	_	IN	_	_	7	VMOD	_	_
13	the	_	DT	_	_	14	NMOD	_	_
14	product	_	NN	_	_	12	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	the	_	DT	_	_	19	NMOD	_	_
17	transforming	_	NN	_	_	19	NMOD	_	_
18	Ha-ras-1	_	NN	_	_	19	NMOD	_	_
19	oncogene	_	NN	_	_	15	PMOD	_	_
20	.	_	.	_	_	3	P	_	_
		
